These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7464868)

  • 21. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
    Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
    Bolte HD
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
    Latour JG; Theroux P; Bourassa MG
    Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulphinpyrazone (Anturan) after myocardial infarction.
    Nicholson MR; Whitlock RM
    N Z Med J; 1979 Sep; 90(644):263. PubMed ID: 390442
    [No Abstract]   [Full Text] [Related]  

  • 25. Myocardial re-infarction and sulphinpyrazone.
    N Z Med J; 1978 Aug; 88(617):106. PubMed ID: 362256
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulphinpyrazone.
    Hopkins S
    Nurs Mirror; 1980 Aug; 151(9):36. PubMed ID: 6995949
    [No Abstract]   [Full Text] [Related]  

  • 27. Overview of recent clinical and methodological advances from clinical trials of cardiovascular disease.
    Friedewald WT; Schoenberger JA
    Control Clin Trials; 1982 Sep; 3(3):259-70. PubMed ID: 6129942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulphinpyrazone (Anturan) after myocardial infarct.
    Watt M
    N Z Med J; 1979 Oct; 90(646):352. PubMed ID: 392352
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA says no to anturane.
    Kolata GB
    Science; 1980 Jun; 208(4448):1130-2. PubMed ID: 6990491
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct].
    Foz M
    Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo platelet hyperactivity and factor VIII related antigen increase long after myocardial infarction. A controlled effect of sulfinpyrazone.
    Cortellaro M; Boschetti C; Beggi P; Polli EE
    Scand J Haematol; 1981 Feb; 26(2):106-14. PubMed ID: 6454960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction.
    S Afr Med J; 1980 Mar; 57(9):301-2. PubMed ID: 6986664
    [No Abstract]   [Full Text] [Related]  

  • 33. The anturane reinfarction trial.
    Sauerbruch T; Kaess H
    N Engl J Med; 1980 Jul; 303(1):49-50. PubMed ID: 6990266
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfinpyrazone after myocardial infarction?
    Beilin LJ
    Med J Aust; 1978 Aug; 2(5):186-8. PubMed ID: 364265
    [No Abstract]   [Full Text] [Related]  

  • 35. Sulfinpyrazone after myocardial infarction.
    Nestel PJ
    Med J Aust; 1980 Jun; 1(12):571-2. PubMed ID: 7402151
    [No Abstract]   [Full Text] [Related]  

  • 36. Anturane works--but how?
    Lancet; 1980 Feb; 1(8163):295. PubMed ID: 6101746
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H
    Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA
    Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
    [No Abstract]   [Full Text] [Related]  

  • 40. On the limitation of therapeutic intervention trials in ischemic heart disease: a clinician's viewpoint.
    Selzer A
    Am J Cardiol; 1982 Jan; 49(1):252-5. PubMed ID: 6976116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.